Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05029869
Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description
Sponsor: University Medical Center Ho Chi Minh City (UMC)
View on ClinicalTrials.gov
Summary
This study aims to evaluate the use of Next Generation Sequencing (NGS) to detect circulating tumor DNA in gastric cancer patients after gastrectomy
Official title: Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2021-10-04
Completion Date
2026-12-30
Last Updated
2025-08-13
Healthy Volunteers
No
Conditions
Interventions
DIAGNOSTIC_TEST
ctDNA
The blood samples for ctDNA and other tumor markers will be first collected within 14 days before surgery, and then be tested after gastrectomy in scheduled interval
Locations (1)
University Medical Center Ho Chi Minh City
Ho Chi Minh City, Vietnam